<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Trephine biopsy evaluation in patients who have undergone high dose chemotherapy with stem cell infusion performed by an experienced pathologist is important in evaluation of hematopoietical restitution, evaluation of complications such as graft rejection, <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, relapse or secondary <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the first week after high dose chemotherapy or radiotherapy bone marrow <z:mpath ids='MPATH_58'>aplasia</z:mpath> is evident </plain></SENT>
<SENT sid="2" pm="."><plain>In the case of accompanying <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>, fragmentation of reticular and collagen fibers is noticeable only following stem cell transplantation </plain></SENT>
<SENT sid="3" pm="."><plain>The first precursors, which appear after the second or third week after transplantation are erythroid precursors found in small groups </plain></SENT>
<SENT sid="4" pm="."><plain>Promyelocytes and myelocytes are observed between the second and fourth week, the ration off erythroid to myeloid populations at that time is 1:1 </plain></SENT>
<SENT sid="5" pm="."><plain>Megakaryocytes ate the last precursors to appear </plain></SENT>
<SENT sid="6" pm="."><plain>Trephine biopsy evaluation is useful in diagnosis of graft rejection, especially in case of a discrepancy between the blood <z:mp ids='MP_0000002'>morphology</z:mp> examination and bone marrow cellularity </plain></SENT>
<SENT sid="7" pm="."><plain>Granuloma formation is an unspecific finding, which requires diagnosis of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0543478" disease_type="Neoplastic Process" abbrv="">Residual disease</z:e> can be recognized in histopathologic examination, or sooner, with immunophenotyping, cytogenetic examination using FISH or PCR </plain></SENT>
<SENT sid="9" pm="."><plain>Secondary <z:hpo ids='HP_0002664'>neoplasms</z:hpo> to high dose radiotherapy or chemotherapy are usually lymphoproliferative processes connected with latent <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infections</z:e>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> myeloblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
</text></document>